English

DermTech, Inc.

EDGAR

CNACU Quarterly report (10-Q) · filed 2024-05-15

51 filing records in this dataset, filed from 2017-05-18 to 2024-05-15. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

3.85 million USD

2024 Q4 · USD

Exact inputs and evidence

Revenue: 3845000 USD Source

Operating margin

-533.37%

2024 Q4 · %

Exact inputs and evidence

Operating Income: -20508000 USD Source
Revenue: 3845000 USD Source

Operating cash flow

-17.1 million USD

2024 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -17100000 USD Source

Free cash flow

-17.1 million USD

2024 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -17100000 USD Source
Capital Expenditure: 0 USD Source

Cash and cash equivalents: 27.6 million USD 2024-03-31 Source
Exact value

27600000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 35 million shares 2024-03-31 Source
Exact value

34962994 shares

Reported share-count change

12.46% · 3.87 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

31088911 shares · 2023-03-31· Source
34962994 shares · 2024-03-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

15.7 million USD

2023-04-01 – 2024-03-31

Exact inputs and evidence

Revenue: 3980000 USD · 2023-04-01 – 2023-06-30 Source
Revenue: 3915000 USD · 2023-07-01 – 2023-09-30 Source
Revenue: 15296000 USD · 2023-01-01 – 2023-12-31 Source
Revenue: 11372000 USD · 2023-01-01 – 2023-09-30 Source
Revenue: 3845000 USD · 2024-01-01 – 2024-03-31 Source

Net income

-89.6 million USD

2023-04-01 – 2024-03-31

Exact inputs and evidence

Net income: -31363000 USD · 2023-04-01 – 2023-06-30 Source
Net income: -19164000 USD · 2023-07-01 – 2023-09-30 Source
Net income: -100900000 USD · 2023-01-01 – 2023-12-31 Source
Net income: -81797000 USD · 2023-01-01 – 2023-09-30 Source
Net income: -20000000 USD · 2024-01-01 – 2024-03-31 Source

Operating cash flow

-72.1 million USD

2023-04-01 – 2024-03-31

Exact inputs and evidence

Operating cash flow: -45229000 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -22028000 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -64272000 USD · 2023-01-01 – 2023-09-30 Source
Operating cash flow: -45229000 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -77000000 USD · 2023-01-01 – 2023-12-31 Source
Operating cash flow: -64272000 USD · 2023-01-01 – 2023-09-30 Source
Operating cash flow: -17100000 USD · 2024-01-01 – 2024-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2024-05-15.

Financial data available through: 2023-12-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2023-12-31
Operating income: 10 of 11 periods available· newest 2023-12-31
Net income: 10 of 11 periods available· newest 2023-12-31
Operating cash flow: 10 of 11 periods available· newest 2023-12-31
Capital expenditure: 7 of 11 periods available· newest 2023-12-31
Total assets: 6 of 11 periods available· newest 2023-12-31
Total liabilities: 6 of 11 periods available· newest 2023-12-31
Current assets: 6 of 11 periods available· newest 2023-12-31
Current liabilities: 6 of 11 periods available· newest 2023-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 2023-12-31
long term debt: No compatible figures in this window
Shares outstanding: 6 of 11 periods available· newest 2023-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+5.4%

Prior period

USD 14.52 million

2022-01-01 – 2022-12-31
Current period

USD 15.3 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

15296000 − 14518000 = 778000 USD

14518000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
15296000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · DermTech, Inc. · 2023-12-31 DermTech, Inc. (edgar:1651944) Year-over-year change in Revenue: 778000 USD Concept: fundies:Revenue Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 15296000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000165194424000014/dmtk-20231231.htm#1153645 Filing: 000165194424000014 Input fundies:Revenue: 14518000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000165194424000014/dmtk-20231231.htm#1154629 Filing: 000165194424000014
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 15.78 million

Prior period

−USD 116.68 million

2022-01-01 – 2022-12-31
Current period

−USD 100.9 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

-100900000 − -116683000 = 15783000 USD

-116683000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
-100900000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · DermTech, Inc. · 2023-12-31 DermTech, Inc. (edgar:1651944) Year-over-year change in Net income: 15783000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -100900000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000165194424000014/dmtk-20231231.htm#1092167 Filing: 000165194424000014 Input fundies:NetIncome: -116683000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000165194424000014/dmtk-20231231.htm#976839 Filing: 000165194424000014
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 18.26 million

Prior period

−USD 95.26 million

2022-01-01 – 2022-12-31
Current period

−USD 77 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

-77000000 − -95260000 = 18260000 USD

-95260000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
-77000000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · DermTech, Inc. · 2023-12-31 DermTech, Inc. (edgar:1651944) Year-over-year change in Operating cash flow: 18260000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -77000000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000165194424000014/dmtk-20231231.htm#1092389 Filing: 000165194424000014 Input fundies:OperatingCashFlow: -95260000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000165194424000014/dmtk-20231231.htm#1036778 Filing: 000165194424000014
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-72.7%

Prior period

USD 3.31 million

2022-01-01 – 2022-12-31
Current period

USD 902,000

2023-01-01 – 2023-12-31

Exact inputs and evidence

902000 − 3305000 = -2403000 USD

3305000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
902000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · DermTech, Inc. · 2023-12-31 DermTech, Inc. (edgar:1651944) Year-over-year change in Capital expenditure: -2403000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 902000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000165194424000014/dmtk-20231231.htm#1041650 Filing: 000165194424000014 Input fundies:CapitalExpenditure: 3305000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000165194424000014/dmtk-20231231.htm#1042213 Filing: 000165194424000014
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2024 2023-01-01 – 2023-12-31

Revenue USD 15.3 million 100% of revenue
Cost of revenue USD 15.02 million 98% of revenue
Operating expenses USD 104.02 million 680% of revenue
Operating income −USD 103.74 million −678% of revenue
Tax, interest and other Derived −USD 2.84 million −19% of revenue
Net income −USD 100.9 million −660% of revenue

Cash

Operating cash flow −USD 77 million −503% of revenue
Capital expenditure USD 902,000 5.9% of revenue
Free cash flow Derived −USD 77.9 million −509% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2019 Operating loss: operating costs were 451% of revenue.
2020 Operating loss: operating costs were 623% of revenue.
2021 Operating loss: operating costs were 700% of revenue.
2022 Operating loss: operating costs were 754% of revenue.
2023 Operating loss: operating costs were 914% of revenue.
2024 Operating loss: operating costs were 778% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2019 2018-01-01 – 2018-12-31	2442000	11002000 Derived	-8560000	1444000 Derived	-10004000	-7617000 Derived	Source 2018-01-01 – 2018-12-31: 2442000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -8560000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -10004000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -7605000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 12000 USD Inspect Capital Expenditure Open source
2020 2019-01-01 – 2019-12-31	3364000	20969000 Derived	-17605000	2525000 Derived	-20130000	-18001000 Derived	Source 2019-01-01 – 2019-12-31: 3364000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -17605000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -20130000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -17791000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 210000 USD Inspect Capital Expenditure Open source
2021 2020-01-01 – 2020-12-31	5885000	41174000 Derived	-35289000	1188000 Derived	-36477000	-30518000 Derived	Source 2020-01-01 – 2020-12-31: 5885000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -35289000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -36477000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -28684000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 1834000 USD Inspect Capital Expenditure Open source
2022 2021-01-01 – 2021-12-31	11838000	89236000 Derived	-77398000	937000 Derived	-78335000	-64826000 Derived	Source 2021-01-01 – 2021-12-31: 11838000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -77398000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -78335000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -62106000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 2720000 USD Inspect Capital Expenditure Open source
2023 2022-01-01 – 2022-12-31	14518000	132683000 Derived	-118165000	-1482000 Derived	-116683000	-98565000 Derived	Source 2022-01-01 – 2022-12-31: 14518000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -118165000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -116683000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -95260000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 3305000 USD Inspect Capital Expenditure Open source
2024 2023-01-01 – 2023-12-31	15296000	119035000 Derived	-103739000	-2839000 Derived	-100900000	-77902000 Derived	Source 2023-01-01 – 2023-12-31: 15296000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -103739000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -100900000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -77000000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 902000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 15.3M 2024

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20192018-12-31	Revenue	2442000	Revenue: 2442000 Open source
20202019-12-31	Revenue	3364000	Revenue: 3364000 Open source
20212020-12-31	Revenue	5885000	Revenue: 5885000 Open source
20222021-12-31	Revenue	11838000	Revenue: 11838000 Open source
20232022-12-31	Revenue	14518000	Revenue: 14518000 Open source
20242023-12-31	Revenue	15296000	Revenue: 15296000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

5.4% 2024

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20192018-12-31	Year over year	No prior comparable period	Revenue: 2442000 Open source
20202019-12-31	Year over year	37.8%	Revenue: 3364000 Open source Revenue: 2442000 Open source
20212020-12-31	Year over year	74.9%	Revenue: 5885000 Open source Revenue: 3364000 Open source
20222021-12-31	Year over year	101.2%	Revenue: 11838000 Open source Revenue: 5885000 Open source
20232022-12-31	Year over year	22.6%	Revenue: 14518000 Open source Revenue: 11838000 Open source
20242023-12-31	Year over year	5.4%	Revenue: 15296000 Open source Revenue: 14518000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -678.2% 2024

Net margin -659.6% 2024

Free cash flow margin -509.3% 2024

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20192018-12-31	Operating margin	-350.5%	Operating Income: -8560000 Open source Revenue: 2442000 Open source
20202019-12-31	Operating margin	-523.3%	Operating Income: -17605000 Open source Revenue: 3364000 Open source
20212020-12-31	Operating margin	-599.6%	Operating Income: -35289000 Open source Revenue: 5885000 Open source
20222021-12-31	Operating margin	-653.8%	Operating Income: -77398000 Open source Revenue: 11838000 Open source
20232022-12-31	Operating margin	-813.9%	Operating Income: -118165000 Open source Revenue: 14518000 Open source
20242023-12-31	Operating margin	-678.2%	Operating Income: -103739000 Open source Revenue: 15296000 Open source
20192018-12-31	Net margin	-409.7%	Net Income: -10004000 Open source Revenue: 2442000 Open source
20202019-12-31	Net margin	-598.4%	Net Income: -20130000 Open source Revenue: 3364000 Open source
20212020-12-31	Net margin	-619.8%	Net Income: -36477000 Open source Revenue: 5885000 Open source
20222021-12-31	Net margin	-661.7%	Net Income: -78335000 Open source Revenue: 11838000 Open source
20232022-12-31	Net margin	-803.7%	Net Income: -116683000 Open source Revenue: 14518000 Open source
20242023-12-31	Net margin	-659.6%	Net Income: -100900000 Open source Revenue: 15296000 Open source
20192018-12-31	Free cash flow margin	-311.9%	Revenue: 2442000 Open source Operating Cash Flow: -7605000 Open source Capital Expenditure: 12000 Open source
20202019-12-31	Free cash flow margin	-535.1%	Revenue: 3364000 Open source Operating Cash Flow: -17791000 Open source Capital Expenditure: 210000 Open source
20212020-12-31	Free cash flow margin	-518.6%	Revenue: 5885000 Open source Operating Cash Flow: -28684000 Open source Capital Expenditure: 1834000 Open source
20222021-12-31	Free cash flow margin	-547.6%	Revenue: 11838000 Open source Operating Cash Flow: -62106000 Open source Capital Expenditure: 2720000 Open source
20232022-12-31	Free cash flow margin	-678.9%	Revenue: 14518000 Open source Operating Cash Flow: -95260000 Open source Capital Expenditure: 3305000 Open source
20242023-12-31	Free cash flow margin	-509.3%	Revenue: 15296000 Open source Operating Cash Flow: -77000000 Open source Capital Expenditure: 902000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -77M 2024

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20192018-12-31	Operating cash flow	-7605000	Operating Cash Flow: -7605000 Open source
20202019-12-31	Operating cash flow	-17791000	Operating Cash Flow: -17791000 Open source
20212020-12-31	Operating cash flow	-28684000	Operating Cash Flow: -28684000 Open source
20222021-12-31	Operating cash flow	-62106000	Operating Cash Flow: -62106000 Open source
20232022-12-31	Operating cash flow	-95260000	Operating Cash Flow: -95260000 Open source
20242023-12-31	Operating cash flow	-77000000	Operating Cash Flow: -77000000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -77.9M 2024

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20192018-12-31	Free cash flow	-7617000	Operating Cash Flow: -7605000 Open source Capital Expenditure: 12000 Open source
20202019-12-31	Free cash flow	-18001000	Operating Cash Flow: -17791000 Open source Capital Expenditure: 210000 Open source
20212020-12-31	Free cash flow	-30518000	Operating Cash Flow: -28684000 Open source Capital Expenditure: 1834000 Open source
20222021-12-31	Free cash flow	-64826000	Operating Cash Flow: -62106000 Open source Capital Expenditure: 2720000 Open source
20232022-12-31	Free cash flow	-98565000	Operating Cash Flow: -95260000 Open source Capital Expenditure: 3305000 Open source
20242023-12-31	Free cash flow	-77902000	Operating Cash Flow: -77000000 Open source Capital Expenditure: 902000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

53.1% 2024

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20192018-12-31	Liabilities / assets	194.5%	Total Liabilities: 11019000 Open source Total Assets: 5664000 Open source
20202019-12-31	Liabilities / assets	34.9%	Total Liabilities: 6350000 Open source Total Assets: 18211000 Open source
20212020-12-31	Liabilities / assets	11.4%	Total Liabilities: 7940000 Open source Total Assets: 69780000 Open source
20222021-12-31	Liabilities / assets	7.5%	Total Liabilities: 18611000 Open source Total Assets: 248309000 Open source
20232022-12-31	Liabilities / assets	34.5%	Total Liabilities: 69722000 Open source Total Assets: 202075000 Open source
20242023-12-31	Liabilities / assets	53.1%	Total Liabilities: 64755000 Open source Total Assets: 121930000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

4.59× 2024

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20192018-12-31	Current assets / current liabilities	0.51×	Current Assets: 5399000 Open source Current Liabilities: 10503000 Open source
20202019-12-31	Current assets / current liabilities	3×	Current Assets: 17150000 Open source Current Liabilities: 5722000 Open source
20212020-12-31	Current assets / current liabilities	12.33×	Current Assets: 66882000 Open source Current Liabilities: 5425000 Open source
20222021-12-31	Current assets / current liabilities	19.11×	Current Assets: 232824000 Open source Current Liabilities: 12181000 Open source
20232022-12-31	Current assets / current liabilities	8.7×	Current Assets: 136037000 Open source Current Liabilities: 15636000 Open source
20242023-12-31	Current assets / current liabilities	4.59×	Current Assets: 61752000 Open source Current Liabilities: 13447000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2017 2016-04-01 – 2017-03-31	−USD 60 Exact value Exact value: -60 USD 2016-04-01 – 2017-03-31: -60 USD Inspect Net Income Open source Share or cite Citation for Net Income · DermTech, Inc. · 2017-03-31 DermTech, Inc. (edgar:1651944) Net Income: -60 USD Concept: fundies:NetIncome Period: 2016-04-01 to 2017-03-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944/explain?concept=fundies%3ANetIncome&period=2017-03-31&surface=latest&period_type=duration&start=2016-04-01&unit=USD&dimensions= Input fundies:NetIncome: -60 USD (2016-04-01 to 2017-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000114420418036605/cnacu-20180331.xml#42242 Filing: 000114420418036605 The citation records this snapshot. The page link may show a newer release later.	USD 2,194 Exact value Exact value: 2194 USD 2016-04-01 – 2017-03-31: 2194 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DermTech, Inc. · 2017-03-31 DermTech, Inc. (edgar:1651944) Operating Cash Flow: 2194 USD Concept: fundies:OperatingCashFlow Period: 2016-04-01 to 2017-03-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944/explain?concept=fundies%3AOperatingCashFlow&period=2017-03-31&surface=latest&period_type=duration&start=2016-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 2194 USD (2016-04-01 to 2017-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000114420418036605/cnacu-20180331.xml#53516 Filing: 000114420418036605 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2018 2017-01-01 – 2017-12-31	−USD 8.37 million Exact value Exact value: -8369000 USD 2017-01-01 – 2017-12-31: -8369000 USD Inspect Net Income Open source Share or cite Citation for Net Income · DermTech, Inc. · 2017-12-31 DermTech, Inc. (edgar:1651944) Net Income: -8369000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8369000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000119312520000753/dmtk-20190930.xml#189477 Filing: 000119312520000753 The citation records this snapshot. The page link may show a newer release later.	−USD 6.2 million Exact value Exact value: -6195000 USD 2017-01-01 – 2017-12-31: -6195000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DermTech, Inc. · 2017-12-31 DermTech, Inc. (edgar:1651944) Operating Cash Flow: -6195000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6195000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000119312520000753/dmtk-20190930.xml#741655 Filing: 000119312520000753 The citation records this snapshot. The page link may show a newer release later.	USD 123,000 Exact value Exact value: 123000 USD 2017-01-01 – 2017-12-31: 123000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DermTech, Inc. · 2017-12-31 DermTech, Inc. (edgar:1651944) Capital Expenditure: 123000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 123000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000119312520000753/dmtk-20190930.xml#742060 Filing: 000119312520000753 The citation records this snapshot. The page link may show a newer release later.	−USD 6.32 million Calculation and evidence -6195000 − 123000 USD Exact free cash flow: -6318000 USD 2017-01-01 – 2017-12-31: -6195000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 123000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DermTech, Inc. · 2017-12-31 DermTech, Inc. (edgar:1651944) Free cash flow: -6318000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6195000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000119312520000753/dmtk-20190930.xml#741655 Filing: 000119312520000753 Input fundies:CapitalExpenditure: 123000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000119312520000753/dmtk-20190930.xml#742060 Filing: 000119312520000753 The citation records this snapshot. The page link may show a newer release later.
2018 2017-04-01 – 2018-03-31	USD 856,407 Exact value Exact value: 856407 USD 2017-04-01 – 2018-03-31: 856407 USD Inspect Net Income Open source Share or cite Citation for Net Income · DermTech, Inc. · 2018-03-31 DermTech, Inc. (edgar:1651944) Net Income: 856407 USD Concept: fundies:NetIncome Period: 2017-04-01 to 2018-03-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944/explain?concept=fundies%3ANetIncome&period=2018-03-31&surface=latest&period_type=duration&start=2017-04-01&unit=USD&dimensions= Input fundies:NetIncome: 856407 USD (2017-04-01 to 2018-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000119312519173682/cnacu-20190331.xml#323345 Filing: 000119312519173682 The citation records this snapshot. The page link may show a newer release later.	−USD 373,391 Exact value Exact value: -373391 USD 2017-04-01 – 2018-03-31: -373391 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DermTech, Inc. · 2018-03-31 DermTech, Inc. (edgar:1651944) Operating Cash Flow: -373391 USD Concept: fundies:OperatingCashFlow Period: 2017-04-01 to 2018-03-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944/explain?concept=fundies%3AOperatingCashFlow&period=2018-03-31&surface=latest&period_type=duration&start=2017-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -373391 USD (2017-04-01 to 2018-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000119312519173682/cnacu-20190331.xml#162158 Filing: 000119312519173682 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2019 2018-01-01 – 2018-12-31	−USD 10 million Exact value Exact value: -10004000 USD 2018-01-01 – 2018-12-31: -10004000 USD Inspect Net Income Open source Share or cite Citation for Net Income · DermTech, Inc. · 2018-12-31 DermTech, Inc. (edgar:1651944) Net Income: -10004000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10004000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000156459020020848/dmtk-20191231.xml#140715 Filing: 000156459020020848 The citation records this snapshot. The page link may show a newer release later.	−USD 7.61 million Exact value Exact value: -7605000 USD 2018-01-01 – 2018-12-31: -7605000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DermTech, Inc. · 2018-12-31 DermTech, Inc. (edgar:1651944) Operating Cash Flow: -7605000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7605000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000156459020020848/dmtk-20191231.xml#160883 Filing: 000156459020020848 The citation records this snapshot. The page link may show a newer release later.	USD 12,000 Exact value Exact value: 12000 USD 2018-01-01 – 2018-12-31: 12000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DermTech, Inc. · 2018-12-31 DermTech, Inc. (edgar:1651944) Capital Expenditure: 12000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 12000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000156459020020848/dmtk-20191231.xml#161303 Filing: 000156459020020848 The citation records this snapshot. The page link may show a newer release later.	−USD 7.62 million Calculation and evidence -7605000 − 12000 USD Exact free cash flow: -7617000 USD 2018-01-01 – 2018-12-31: -7605000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 12000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DermTech, Inc. · 2018-12-31 DermTech, Inc. (edgar:1651944) Free cash flow: -7617000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7605000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000156459020020848/dmtk-20191231.xml#160883 Filing: 000156459020020848 Input fundies:CapitalExpenditure: 12000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000156459020020848/dmtk-20191231.xml#161303 Filing: 000156459020020848 The citation records this snapshot. The page link may show a newer release later.
2019 2018-04-01 – 2019-03-31	USD 944,458 Exact value Exact value: 944458 USD 2018-04-01 – 2019-03-31: 944458 USD Inspect Net Income Open source Share or cite Citation for Net Income · DermTech, Inc. · 2019-03-31 DermTech, Inc. (edgar:1651944) Net Income: 944458 USD Concept: fundies:NetIncome Period: 2018-04-01 to 2019-03-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944/explain?concept=fundies%3ANetIncome&period=2019-03-31&surface=latest&period_type=duration&start=2018-04-01&unit=USD&dimensions= Input fundies:NetIncome: 944458 USD (2018-04-01 to 2019-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000119312519173682/cnacu-20190331.xml#323202 Filing: 000119312519173682 The citation records this snapshot. The page link may show a newer release later.	−USD 444,455 Exact value Exact value: -444455 USD 2018-04-01 – 2019-03-31: -444455 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DermTech, Inc. · 2019-03-31 DermTech, Inc. (edgar:1651944) Operating Cash Flow: -444455 USD Concept: fundies:OperatingCashFlow Period: 2018-04-01 to 2019-03-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944/explain?concept=fundies%3AOperatingCashFlow&period=2019-03-31&surface=latest&period_type=duration&start=2018-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -444455 USD (2018-04-01 to 2019-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000119312519173682/cnacu-20190331.xml#161956 Filing: 000119312519173682 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2020 2019-01-01 – 2019-12-31	−USD 20.13 million Exact value Exact value: -20130000 USD 2019-01-01 – 2019-12-31: -20130000 USD Inspect Net Income Open source Share or cite Citation for Net Income · DermTech, Inc. · 2019-12-31 DermTech, Inc. (edgar:1651944) Net Income: -20130000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -20130000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000156459022009635/dmtk-10k_20211231.htm#3166653 Filing: 000156459022009635 The citation records this snapshot. The page link may show a newer release later.	−USD 17.79 million Exact value Exact value: -17791000 USD 2019-01-01 – 2019-12-31: -17791000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DermTech, Inc. · 2019-12-31 DermTech, Inc. (edgar:1651944) Operating Cash Flow: -17791000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -17791000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000156459022009635/dmtk-10k_20211231.htm#2770167 Filing: 000156459022009635 The citation records this snapshot. The page link may show a newer release later.	USD 210,000 Exact value Exact value: 210000 USD 2019-01-01 – 2019-12-31: 210000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DermTech, Inc. · 2019-12-31 DermTech, Inc. (edgar:1651944) Capital Expenditure: 210000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 210000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000156459022009635/dmtk-10k_20211231.htm#2797981 Filing: 000156459022009635 The citation records this snapshot. The page link may show a newer release later.	−USD 18 million Calculation and evidence -17791000 − 210000 USD Exact free cash flow: -18001000 USD 2019-01-01 – 2019-12-31: -17791000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 210000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DermTech, Inc. · 2019-12-31 DermTech, Inc. (edgar:1651944) Free cash flow: -18001000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -17791000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000156459022009635/dmtk-10k_20211231.htm#2770167 Filing: 000156459022009635 Input fundies:CapitalExpenditure: 210000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000156459022009635/dmtk-10k_20211231.htm#2797981 Filing: 000156459022009635 The citation records this snapshot. The page link may show a newer release later.
2021 2020-01-01 – 2020-12-31	−USD 36.48 million Exact value Exact value: -36477000 USD 2020-01-01 – 2020-12-31: -36477000 USD Inspect Net Income Open source Share or cite Citation for Net Income · DermTech, Inc. · 2020-12-31 DermTech, Inc. (edgar:1651944) Net Income: -36477000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -36477000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000156459022009635/dmtk-10k_20211231.htm#3172589 Filing: 000156459022009635 The citation records this snapshot. The page link may show a newer release later.	−USD 28.68 million Exact value Exact value: -28684000 USD 2020-01-01 – 2020-12-31: -28684000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DermTech, Inc. · 2020-12-31 DermTech, Inc. (edgar:1651944) Operating Cash Flow: -28684000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -28684000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000156459022009635/dmtk-10k_20211231.htm#2768186 Filing: 000156459022009635 The citation records this snapshot. The page link may show a newer release later.	USD 1.83 million Exact value Exact value: 1834000 USD 2020-01-01 – 2020-12-31: 1834000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DermTech, Inc. · 2020-12-31 DermTech, Inc. (edgar:1651944) Capital Expenditure: 1834000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1834000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000156459022009635/dmtk-10k_20211231.htm#2796093 Filing: 000156459022009635 The citation records this snapshot. The page link may show a newer release later.	−USD 30.52 million Calculation and evidence -28684000 − 1834000 USD Exact free cash flow: -30518000 USD 2020-01-01 – 2020-12-31: -28684000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 1834000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DermTech, Inc. · 2020-12-31 DermTech, Inc. (edgar:1651944) Free cash flow: -30518000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -28684000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000156459022009635/dmtk-10k_20211231.htm#2768186 Filing: 000156459022009635 Input fundies:CapitalExpenditure: 1834000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000156459022009635/dmtk-10k_20211231.htm#2796093 Filing: 000156459022009635 The citation records this snapshot. The page link may show a newer release later.
2022 2021-01-01 – 2021-12-31	−USD 78.34 million Exact value Exact value: -78335000 USD 2021-01-01 – 2021-12-31: -78335000 USD Inspect Net Income Open source Share or cite Citation for Net Income · DermTech, Inc. · 2021-12-31 DermTech, Inc. (edgar:1651944) Net Income: -78335000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -78335000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000165194423000010/dmtk-20221231.htm#1032850 Filing: 000165194423000010 The citation records this snapshot. The page link may show a newer release later.	−USD 62.11 million Exact value Exact value: -62106000 USD 2021-01-01 – 2021-12-31: -62106000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DermTech, Inc. · 2021-12-31 DermTech, Inc. (edgar:1651944) Operating Cash Flow: -62106000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -62106000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000165194423000010/dmtk-20221231.htm#1113605 Filing: 000165194423000010 The citation records this snapshot. The page link may show a newer release later.	USD 2.72 million Exact value Exact value: 2720000 USD 2021-01-01 – 2021-12-31: 2720000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DermTech, Inc. · 2021-12-31 DermTech, Inc. (edgar:1651944) Capital Expenditure: 2720000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2720000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000165194423000010/dmtk-20221231.htm#1121430 Filing: 000165194423000010 The citation records this snapshot. The page link may show a newer release later.	−USD 64.83 million Calculation and evidence -62106000 − 2720000 USD Exact free cash flow: -64826000 USD 2021-01-01 – 2021-12-31: -62106000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 2720000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DermTech, Inc. · 2021-12-31 DermTech, Inc. (edgar:1651944) Free cash flow: -64826000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -62106000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000165194423000010/dmtk-20221231.htm#1113605 Filing: 000165194423000010 Input fundies:CapitalExpenditure: 2720000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000165194423000010/dmtk-20221231.htm#1121430 Filing: 000165194423000010 The citation records this snapshot. The page link may show a newer release later.
2023 2022-01-01 – 2022-12-31	−USD 116.68 million Exact value Exact value: -116683000 USD 2022-01-01 – 2022-12-31: -116683000 USD Inspect Net Income Open source Share or cite Citation for Net Income · DermTech, Inc. · 2022-12-31 DermTech, Inc. (edgar:1651944) Net Income: -116683000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -116683000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000165194424000014/dmtk-20231231.htm#976839 Filing: 000165194424000014 The citation records this snapshot. The page link may show a newer release later.	−USD 95.26 million Exact value Exact value: -95260000 USD 2022-01-01 – 2022-12-31: -95260000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DermTech, Inc. · 2022-12-31 DermTech, Inc. (edgar:1651944) Operating Cash Flow: -95260000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -95260000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000165194424000014/dmtk-20231231.htm#1036778 Filing: 000165194424000014 The citation records this snapshot. The page link may show a newer release later.	USD 3.31 million Exact value Exact value: 3305000 USD 2022-01-01 – 2022-12-31: 3305000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DermTech, Inc. · 2022-12-31 DermTech, Inc. (edgar:1651944) Capital Expenditure: 3305000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3305000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000165194424000014/dmtk-20231231.htm#1042213 Filing: 000165194424000014 The citation records this snapshot. The page link may show a newer release later.	−USD 98.57 million Calculation and evidence -95260000 − 3305000 USD Exact free cash flow: -98565000 USD 2022-01-01 – 2022-12-31: -95260000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 3305000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DermTech, Inc. · 2022-12-31 DermTech, Inc. (edgar:1651944) Free cash flow: -98565000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -95260000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000165194424000014/dmtk-20231231.htm#1036778 Filing: 000165194424000014 Input fundies:CapitalExpenditure: 3305000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000165194424000014/dmtk-20231231.htm#1042213 Filing: 000165194424000014 The citation records this snapshot. The page link may show a newer release later.
2024 2023-01-01 – 2023-12-31	−USD 100.9 million Exact value Exact value: -100900000 USD 2023-01-01 – 2023-12-31: -100900000 USD Inspect Net Income Open source Share or cite Citation for Net Income · DermTech, Inc. · 2023-12-31 DermTech, Inc. (edgar:1651944) Net Income: -100900000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -100900000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000165194424000014/dmtk-20231231.htm#1092167 Filing: 000165194424000014 The citation records this snapshot. The page link may show a newer release later.	−USD 77 million Exact value Exact value: -77000000 USD 2023-01-01 – 2023-12-31: -77000000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DermTech, Inc. · 2023-12-31 DermTech, Inc. (edgar:1651944) Operating Cash Flow: -77000000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -77000000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000165194424000014/dmtk-20231231.htm#1092389 Filing: 000165194424000014 The citation records this snapshot. The page link may show a newer release later.	USD 902,000 Exact value Exact value: 902000 USD 2023-01-01 – 2023-12-31: 902000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DermTech, Inc. · 2023-12-31 DermTech, Inc. (edgar:1651944) Capital Expenditure: 902000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 902000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000165194424000014/dmtk-20231231.htm#1041650 Filing: 000165194424000014 The citation records this snapshot. The page link may show a newer release later.	−USD 77.9 million Calculation and evidence -77000000 − 902000 USD Exact free cash flow: -77902000 USD 2023-01-01 – 2023-12-31: -77000000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 902000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DermTech, Inc. · 2023-12-31 DermTech, Inc. (edgar:1651944) Free cash flow: -77902000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1651944?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -77000000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000165194424000014/dmtk-20231231.htm#1092389 Filing: 000165194424000014 Input fundies:CapitalExpenditure: 902000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1651944/000165194424000014/dmtk-20231231.htm#1041650 Filing: 000165194424000014 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

51 filings · 1,853 latest values · 1,853 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001651944, 1651944, CNACU, DMTK, edgar:1651944

Also known as Constellation Alpha Capital Corp., DERMTECH, INC., DermTech, Inc.

DermTech, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2024 2023-01-01 – 2023-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation